VolitionRx Limited (NYSE AMERICAN: VNRX) ('Volition'), a multi-national epigenetics company, today announces the results of a study which shows that an automated Nu.Q® Cancer immunoassay test in ...

The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the blood of someone who doesn’t have the disease. When used alongside the ...

The assay was reworked as a consequence ... and third- and fourth-generation tests offer very high performances. Immunoassays must be correctly selected and used for the population being tested.

Expansion of government screening programs, rise in prevalence of hepatitis c & need for its early detection, and advancements in diagnostic technologies drive the growth of the global hepatitis C ...

There are several types of these tests. An immunoassay (IA) test is most common because it is the quickest and most cost-effective. However, IA tests can give false-positive results. In this case ...

A factor VIII assay tests for a protein involved in blood clotting. If you produce less of this protein, it may indicate a bleeding disorder. Some people may also have high levels of this ...

Quick, on-the-spot drug tests, often called point-of-use or rapid tests, are designed to give a fast indication of possible ...

With throughput of up to 800 clinical chemistry tests per hour and 100 immunoassay tests per hour, this analyzer delivers precise and reliable results critical for timely clinical decision-making.